Statement of Retraction: Fetal gender, serum human chorionic gonadotropin, and testosterone in women with preeclampsia
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Hypertension in Pregnancy |
| Online Access: | https://www.tandfonline.com/doi/10.1080/10641955.2025.2496571 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fertility Rates of Ewes Treated with Medroxyprogesterone and Injected with Equine Chorionic Gonadotropin plus Human Chorionic Gonadotropin in Anoestrous Season
by: I. W. Santos, et al.
Published: (2010-01-01) -
Weekly changes in serum -human chorionic gonadotropin, estradiol, and progesterone levels for pregnancy assessment in women with unexplained recurrent miscarriage
by: Ruide Su, et al.
Published: (2025-04-01) -
Development of molecularly imprinted polymers for the detection of human chorionic gonadotropin
by: Radvilė Zubrytė, et al.
Published: (2025-03-01) -
Evaluating cut‐off levels for progesterone, β human chorionic gonadotropin and β human chorionic gonadotropin ratio to exclude pregnancy viability in women with a pregnancy of unknown location: A prospective multicenter cohort study
by: Shabnam Bobdiwala, et al.
Published: (2022-01-01) -
Predictive value of pre-delivery serum b-human chorionic gonadotropin, fibrinogen, and homocysteine for pregnancy-induced hypertension
by: Lin Hani, et al.
Published: (2025-01-01)